A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Small Cell Lung Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Highlands Oncology Group, Springdale, Arkansas, United States

    Contact: Study coordinator (Principal Investigator)
  • Clinical Research Providence Medical Foundation, Fullerton, California, United States

    Contact: Study coordinator (Principal Investigator)
  • UCLA Hematology-Oncology, Los Angeles, California, United States

    Contact: Study coordinator (Principal Investigator)
  • UCSF Mission Bay Mission Hall, San Francisco, California, United States

    Contact: Study coordinator (Principal Investigator)
  • University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Principal Investigator)
  • AdventHealth Orlando, Cancer Institute, Orlando, Florida, United States

    Contact: Study coordinator (Principal Investigator)
  • H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, United States

    Contact: Study coordinator (Principal Investigator)
  • Rush MD Anderson Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Principal Investigator)
  • Baptist Health Lexington, Lexington, Kentucky, United States

    Contact: Study coordinator (Principal Investigator)
  • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Principal Investigator)
  • John Hopkins School of Medicine, Baltimore, Maryland, United States

    Contact: Study coordinator (Principal Investigator)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Principal Investigator)
  • Henry Ford Health System, Detroit, Michigan, United States

    Contact: Study coordinator (Principal Investigator)
  • Mercy Clinic Oncology and Hematology Sindelar Cancer Center, St Louis, Missouri, United States

    Contact: Study coordinator (Principal Investigator)
  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Principal Investigator)
  • Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

    Contact: Study coordinator (Principal Investigator)
  • Astera Cancer Care, East Brunswick, New Jersey, United States

    Contact: Study coordinator (Principal Investigator)
  • Hackensack Meridian Health Jsumc, Neptune City, New Jersey, United States

    Contact: Study coordinator (Principal Investigator)
  • Clinical Research Alliance, Inc, Lake Success, New York, United States

    Contact: Study coordinator (Principal Investigator)
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York, New York, United States

    Contact: Study coordinator (Principal Investigator)
  • New York University Cancer Center - Laura and Isaac, New York, New York, United States

  • Montefiore Medical Center Prime, The Bronx, New York, United States

    Contact: Study coordinator (Principal Investigator)
  • Cleveland Clinic Mercy Hospital, Canton, Ohio, United States

    Contact: Study coordinator (Principal Investigator)
  • Oncology/Hematology Care Clinical Trials, Llc, Cincinnati, Ohio, United States

    Contact: Study coordinator (Principal Investigator)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Principal Investigator)
  • THE WEST CLINIC, PLLC dba West Cancer Center, Germantown, Tennessee, United States

    Contact: Study coordinator (Principal Investigator)
  • Houston Methodist Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Principal Investigator)
  • University of Texas Md Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Principal Investigator)
  • Texas Oncology, P.A. - Tyler, Tyler, Texas, United States

    Contact: Study coordinator (Principal Investigator)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Principal Investigator)
  • Ballarat Base Hospital, Ballarat, Australia

    Contact: Study coordinator (Principal Investigator)
  • Flinders Medical Centre (Fmc), Bedford Park, Australia

    Contact: Study coordinator (Principal Investigator)
  • Chris O Brien Lifehouse, Camperdown, Australia

    Contact: Study coordinator (Principal Investigator)
  • Sunshine Hospital, St Albans, Australia

    Contact: Study coordinator (Principal Investigator)
  • St John of God Subiaco Hospital, Subiaco, Australia

  • Townsville Cancer Centre, Townsville, Australia

    Contact: Study coordinator (Principal Investigator)
  • Princess Alexandra Hospital, Woolloongabba, Australia

    Contact: Study coordinator (Principal Investigator)
  • Landeskrankenhaus Feldkirch, Feldkirch, Austria

    Contact: Study coordinator (Principal Investigator)
  • Landesklinikum Krems, Krems, Austria

    Contact: Study coordinator (Principal Investigator)
  • Kepler University Hospital, Linz, Austria

    Contact: Study coordinator (Principal Investigator)
  • Wiener Gesundheitsverband Klinik Penzing, Vienna, Austria

    Contact: Study coordinator (Principal Investigator)
  • Klinik Floridsdorf, Vienna, Austria

    Contact: Study coordinator (Principal Investigator)
  • Cliniques Universitaires Saint-Luc, Brussels, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Universitair Ziekenhuis Antwerpen, Edegem, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Jessa Ziekenhuis Hospital, Hasselt, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Centre Hospitalier Universitaire de Liege, Liège, Belgium

    Contact: Study coordinator (Principal Investigator)
  • AZ DELTA, Roeselare, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Chu Ucl Namur, Yvoir, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Departmento de Pesquisa Clinica- Hospital de Amor de Barretos, Barretos, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Cepon - Centro de Pesquisas Oncolăgicas de Santa Catarina, Florianópolis, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Clínica de Neoplasias Litoral, Itajaí, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital São Lucas Da Pucrs, Porto Alegre, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Cepho Centro de Estudos E Pesquisas de Hematologia E Oncologia, Santo André, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto, São José do Rio Preto, Brazil

    Contact: Study coordinator (Principal Investigator)
  • ICESP Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital Sirio-Libanes, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital Beneficăncia Portuguesa de Săo Paulo, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital Alemão Oswaldo Cruz, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • A. C. Camargo Cancer Center, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • William Osler Health System - Brampton Civic Hospital, Brampton, Canada

  • Cross Cancer Institute, Edmonton, Canada

    Contact: Study coordinator (Principal Investigator)
  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Québec, Canada

    Contact: Study coordinator (Principal Investigator)
  • Princess Margaret Cancer Center, Toronto, Canada

    Contact: Study coordinator (Principal Investigator)
  • Cancercare Manitoba, Winnipeg, Canada

    Contact: Study coordinator (Principal Investigator)
  • China-Japan Friendship Hospital, Beijing, China

  • Beijing Cancer Hospital, Beijing, China

    Contact: Study coordinator (Principal Investigator)
  • Beijing Chest Hospital,Capital Medical University, Beijing, China

    Contact: Study coordinator (Principal Investigator)
  • Jilin Province Tumor Hospital, Changchun, China

    Contact: Study coordinator (Principal Investigator)
  • Hunan Cancer Hospital, Changsha, China

    Contact: Study coordinator (Principal Investigator)
  • Sichuan Cancer Hospital, Chengdu, China

    Contact: Study coordinator (Principal Investigator)
  • West China Hospital, Sichuan University, Chengdu, China

    Contact: Study coordinator (Principal Investigator)
  • Chongqing University Cancer Hospital, Chongqing, China

    Contact: Study coordinator (Principal Investigator)
  • Harbin Medical University Cancer Hospital, Haerbin, China

    Contact: Study coordinator (Principal Investigator)
  • The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

    Contact: Study coordinator (Principal Investigator)
  • Zhejiang Cancer Hospital, Hangzhou, China

    Contact: Study coordinator (Principal Investigator)
  • The Second Affiliated Hospital of Nanchang University, Jiangxi, China

    Contact: Study coordinator (Principal Investigator)
  • Shandong Cancer Hospital, Jinan, China

    Contact: Study coordinator (Principal Investigator)
  • Linyi Cancer Hospital, Linyi, China

    Contact: Study coordinator (Principal Investigator)
  • The Second Peoples Hospital of Neijiang, Neijiang, China

    Contact: Study coordinator (Principal Investigator)
  • Yantai Yuhuangding Hospital, Shandong, China

  • Fudan University Shanghai Cancer Center, Shanghai, China

    Contact: Study coordinator (Principal Investigator)
  • Liaoning Cancer Hospital & Institute, Shenyang, China

  • Tianjin Medical University Cancer Institute & Hospital, Tianjin, China

    Contact: Study coordinator (Principal Investigator)
  • The Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, China

    Contact: Study coordinator (Principal Investigator)
  • Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    Contact: Study coordinator (Principal Investigator)
  • Huazhong University of Science and Technology - Tongji Medical College - Tongji Hospital Tjh, Wuhan, China

    Contact: Study coordinator (Principal Investigator)
  • Hubei Cancer Hospital, Wuhan, China

    Contact: Study coordinator (Principal Investigator)
  • The First Affiliated Hospital of Xiân Jiaotong University, Xi'an, China

  • Xiangyang Central Hospital, Xiangyang, China

    Contact: Study coordinator (Principal Investigator)
  • Henan Cancer Hospital, Zhengzhou, China

    Contact: Study coordinator (Principal Investigator)
  • Krajska Nemocnice Liberec A.S., Liberec, Czechia

    Contact: Study coordinator (Principal Investigator)
  • Fakultni Nemocnice Olomouc, Olomouc, Czechia

    Contact: Study coordinator (Principal Investigator)
  • Fakultni Thomayerova Nemocnice, Prague, Czechia

    Contact: Study coordinator (Principal Investigator)
  • Institut Sainte Catherine, Avignon, France

    Contact: Study coordinator (Principal Investigator)
  • Chu Bordeaux, Bordeaux, France

    Contact: Study coordinator (Principal Investigator)
  • Centre Hospitalier Intercommunal de Crăteil, Créteil, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Cœur Poumon CHU de Lille, Lille, France

  • Chu Limoges - Hopital Du Cluzeau, Limoges, France

    Contact: Study coordinator (Principal Investigator)
  • Centre Léon Bérard, Lyon, France

    Contact: Study coordinator (Principal Investigator)
  • Assistance Publique-Hăpitaux de Marseille, Marseille, France

    Contact: Study coordinator (Principal Investigator)
  • Hopital Arnaud de Villeneuve, Montpellier, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Régional Du Cancer de Montpellier, Montpellier, France

    Contact: Study coordinator (Principal Investigator)
  • Ch de Mulhouse - Hăpital Emile Muller, Mulhouse, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Curie - Site de Paris, Paris, France

    Contact: Study coordinator (Principal Investigator)
  • Hopital Tenon, Paris, France

    Contact: Study coordinator (Principal Investigator)
  • Chu Rennes - Hopital Pontchaillou, Rennes, France

  • CHU de Saint Etienne, Saint-Etienne, France

    Contact: Study coordinator (Principal Investigator)
  • Chu Nantes - Hăpital Guillaume Et Renă Laănnec, Saint-Herblain, France

    Contact: Study coordinator (Principal Investigator)
  • Institut de Cancerologie de La Loire, Saint-Priest-en-Jarez, France

    Contact: Study coordinator (Principal Investigator)
  • Hăpital Foch, Suresnes, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Gustave Roussy, Villejuif, France

    Contact: Study coordinator (Principal Investigator)
  • Evangelische Lungenklinik Berlin, Berlin, Germany

    Contact: Study coordinator (Principal Investigator)
  • Helios Klinikum Erfurt, Erfurt, Germany

    Contact: Study coordinator (Principal Investigator)
  • Universtitaetsklinikum Essen, Essen, Germany

    Contact: Study coordinator (Principal Investigator)
  • Krankenhaus Nordwest Gmbh, Frankfurt, Germany

    Contact: Study coordinator (Principal Investigator)
  • Universitaetsklinikum Frankfurt Goethe-Universitaet, Frankfurt am Main, Germany

    Contact: Study coordinator (Principal Investigator)
  • Asklepios Fachkliniken Muenchen-Gauting, Gauting, Germany

    Contact: Study coordinator (Principal Investigator)
  • Srh Wald-Klinikum Gera Gmbh, Gera, Germany

    Contact: Study coordinator (Principal Investigator)
  • UNIVERSITATSKLINIKUM GIeBEN UND MARBURG GMBH, Giessen, Germany

    Contact: Study coordinator (Principal Investigator)
  • Asklepios Klinik Harburg, Hamburg, Germany

    Contact: Study coordinator (Principal Investigator)
  • Lki Lungenfachklinik Immenhausen, Immenhausen, Germany

    Contact: Study coordinator (Principal Investigator)
  • Staedtisches Krankenhaus Kiel, Kiel, Germany

    Contact: Study coordinator (Principal Investigator)
  • Johannes Wesling Klinikum Minden, Minden, Germany

    Contact: Study coordinator (Principal Investigator)
  • Pius-Hospital Oldenburg, Oldenburg, Germany

    Contact: Study coordinator (Principal Investigator)
  • Universitaetsklinikum Ulm, Ulm, Germany

    Contact: Study coordinator (Principal Investigator)
  • 'Henry Dynant' Hospital Center, Athens, Greece

    Contact: Study coordinator (Principal Investigator)
  • General Hospital of Athens of Chest Diseases 'Sotiria', Athens, Greece

    Contact: Study coordinator (Principal Investigator)
  • General Hospital of Athens Alexandra, Athens, Greece

    Contact: Study coordinator (Principal Investigator)
  • University General Hospital "Attikon", Chaïdári, Greece

    Contact: Study coordinator (Principal Investigator)
  • University General Hospital of Larissa, Larissa, Greece

    Contact: Study coordinator (Principal Investigator)
  • General Hospital of Patra Agios Andreas, Pátrai, Greece

    Contact: Study coordinator (Principal Investigator)
  • Metropolitan Hospital, Piraeus, Greece

    Contact: Study coordinator (Principal Investigator)
  • St Luke'S Hospital, Thessaloniki, Greece

    Contact: Study coordinator (Principal Investigator)
  • Semmelweis Egyetem, Budapest, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Orszagos Koranyi Pulmonologiai Intezet, Budapest, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Orszagos Onkologiai Intezet, Budapest, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz, Győr, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Bács-Kiskun Vármegyei Oktatókórház, Kecskemét, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Istituto Tumori Giovanni Paolo Ii Irccs Ospedale Oncologico Bari, Bari, Italy

    Contact: Study coordinator (Principal Investigator)
  • Humanitas Gavazzeni, Bergamo, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia (Presidio Spedali Civili), Brescia, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliera Universitaria Policlinico - Vittorio Emanuele (Presidio Gaspare Rodolico), Catania, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliero Universitaria Renato Dulbecco, Catanzaro, Italy

    Contact: Study coordinator (Principal Investigator)
  • Istituto Nazionale Per La Ricerca Sul Cancro Di Genova, Genova, Italy

    Contact: Study coordinator (Principal Investigator)
  • Ospedale San Raffaele, Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • IEO Istituto Europeo di Oncologia, Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Socio Sanitaria Territoriale Di Monza (Presidio San Gerardo), Monza, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliera Universitaria- Universită Degli Studi Della Campania Âluigi Vanvitelliâ, Naples, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliero Universitaria Di Parma, Parma, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliera Di Perugia Ospedale S. Maria Della Misericordia, Perugia, Italy

    Contact: Study coordinator (Principal Investigator)
  • Istituto Nazionale Tumori Regina Elena Irccs, Roma, Italy

    Contact: Study coordinator (Principal Investigator)
  • Istituto Clinico Humanitas, Rozzano, Italy

    Contact: Study coordinator (Principal Investigator)
  • Centro Ricerche Cliniche Di Verona S.R.L., Verona, Italy

    Contact: Study coordinator (Principal Investigator)
  • National Cancer Center Hospital, Chūōku, Japan

    Contact: Study coordinator (Principal Investigator)
  • Kyushu University Hospital, Fukuoka, Japan

    Contact: Study coordinator (Principal Investigator)
  • Kansai Medical University Hospital, Hirakata-shi, Japan

    Contact: Study coordinator (Principal Investigator)
  • National Cancer Center Hospital East, Kashiwa, Japan

    Contact: Study coordinator (Principal Investigator)
  • The Cancer Institute Hospital of Jfcr, Kōtoku, Japan

    Contact: Study coordinator (Principal Investigator)
  • National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Shizuoka Cancer Center, Nakatogari, Japan

    Contact: Study coordinator (Principal Investigator)
  • Okayama University Hospital, Okayama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Kindai University Hospital, Osaka-Sakai, Japan

    Contact: Study coordinator (Principal Investigator)
  • Kitasato University Hospital, Sagamihara, Japan

    Contact: Study coordinator (Principal Investigator)
  • National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan

    Contact: Study coordinator (Principal Investigator)
  • Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Japan

    Contact: Study coordinator (Principal Investigator)
  • Wakayama Medical University Hospital, Wakayama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Netherlands Cancer Institute, Amsterdam, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Maastricht University Medical Center, Maastricht, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Etz Elisabeth, Tilburg, Netherlands

  • Centrum Onkologii Im. Prof. F. Lukaszczyka W Bydgoszczy, Bydgoszcz, Poland

    Contact: Study coordinator (Principal Investigator)
  • Instytut Centrum Zdrowia Matki Polki, Lodz, Poland

    Contact: Study coordinator (Principal Investigator)
  • Mazowieckie Centrum Leczenia Chorob Pluc I Gruzlicy, Otwock, Poland

    Contact: Study coordinator (Principal Investigator)
  • Szpital Specjalistyczny W Prabutach, Prabuty, Poland

    Contact: Study coordinator (Principal Investigator)
  • Provita Prolife, Tomaszów Mazowiecki, Poland

    Contact: Study coordinator (Principal Investigator)
  • Centro Hospitalar E Universitărio de Coimbra E.P.E., Coimbra, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Hospital Da Senhora Da Oliveira Guimarăes, Guimarães, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Hospital Da Luz, Lisbon, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Centro Hospitalar de Lisboa Norte, E.P.E. - Hospital Pulido Valente, Lisbon, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Centro Hospitalar Do Porto, E.P.E. - Hospital de Santo António, Porto, Portugal

    Contact: Study coordinator (Principal Investigator)
  • S.C Radiotherapy Center Cluj S.R.L, Bucharest, Romania

    Contact: Study coordinator (Principal Investigator)
  • Institutul Oncologic 'Prof. Dr. Ion Chiricuta' Cluj Napoca, Cluj-Napoca, Romania

    Contact: Study coordinator (Principal Investigator)
  • S.C Centrul de Oncologie Sfantul Nectarie Craiova, Craiova, Romania

    Contact: Study coordinator (Principal Investigator)
  • S.C. Sigmedical Services Srl, Suceava, Romania

    Contact: Study coordinator (Principal Investigator)
  • Chungbuk National University Hospital, Cheongju-si, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Kyungpook National University Chilgok Hospital, Daegu, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Seoul National University Bundang Hospital, Seongnam-si, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Samsung Medical Center, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Seoul National University Hospital, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Asan Medical Center, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • The Catholic University of Korea, St. Vincent'S Hospital, Suwon, South Korea

  • Ajou University Hospital, Suwon, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Hospital Clinic de Barcelona, Barcelona, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital de La Santa Creu I Sant Pau, Barcelona, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitari Vall D'Hebron, Barcelona, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Reina Sofia, Córdoba, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Ciudad de Jaen, Jaén, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital de Especialidades de Jerez de La Frontera, Jerez de la Frontera, Spain

    Contact: Study coordinator (Principal Investigator)
  • Ico L'Hospitalet - Hospital Duran I Reynals, L'Hospitalet de Llobregat, Spain

    Contact: Study coordinator (Principal Investigator)
  • Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital General Universitario Gregorio Marañon, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Ramon Y Cajal, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario 12 de Octubre, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario La Paz, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Regional Universitario de Malaga, Málaga, Spain

  • Hospital Universitario Virgen Macarena, Seville, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Virgen Del Rocio, Seville, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Nuestra Señora de Valme, Seville, Spain

    Contact: Study coordinator (Principal Investigator)
  • Inselspital - Universitaetsspital Bern, Bern, Switzerland

    Contact: Study coordinator (Principal Investigator)
  • Kantonsspital St. Gallen, Sankt Gallen, Switzerland

    Contact: Study coordinator (Principal Investigator)
  • Hfr Fribourg/Kantonsspital Fribourg, Villars-sur-Glâne, Switzerland

    Contact: Study coordinator (Principal Investigator)
  • Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • China Medical University Hospital, Taichung, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Taichung Veterans General Hospital, Taichung, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • National Cheng Kung University Hospitalx, Tainan, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • National Taiwan University Cancer Centre, Taipei, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Taipei Medical University Hospital, Taipei, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Taipei Veterans General Hospital, Taipei, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Chang Gung Memorial Hospital, Taoyuan City, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Ankara Bilkent City Hospital, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Dicle University, Medical Faculty, Diyarbakır, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Goztepe Prof Dr Suleyman Yalcin City Hospital, Istanbul, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Istanbul, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Medipol University Medical Faculty, Istanbul, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Izmir Medicalpark Hospital, Izmir, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Birmingham Heartlands Hospital, Birmingham, United Kingdom

    Contact: Study coordinator (Principal Investigator)
  • St James'S University Hospital, Leeds, United Kingdom

    Contact: Study coordinator (Principal Investigator)
  • Churchill Hospital, Oxford, United Kingdom

    Contact: Study coordinator (Principal Investigator)
מובילי המחקר
  • Global Clinical Director

    Study Director

    Daiichi Sankyo